Tecan Accelerates Data-Driven Lab Journey With Agentic AI Developments Powered by NVIDIA
Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the integration of Agentic AI capabilities into its lab analytics platform Introspect, leveraging NVIDIA BioNeMo Agent Toolkit. The NVIDIA BioNeMo Agent Toolkit enables AI agents to access scientific AI capabilities directly within the Introspect platform, helping laboratories to optimize operations. Agentic AI will allow laboratories to move beyond traditional monitoring and reactive troubleshooting toward proactive actions that help prevent issues before they impact performance, quality, or scientific outcomes. Early access to the enhanced Introspect platform is available, with applications focused on pharmaceutical, biotechnology, and clinical laboratory environments.
A milestone in the collaboration announced in March 2026, this Agentic AI development demonstrates advancement of Tecan and NVIDIA’s shared vision of enabling Data-Driven Laboratories with AI-powered platforms designed to accelerate scientific discovery and improve laboratory productivity.
Agentic AI introduces a new paradigm for laboratory operations. Rather than identifying problems after they occur, intelligent agents can continuously analyze laboratory data, workflows, and system performance to uncover hidden patterns that limit throughput, constrain scalability, or reduce operational efficiency. By transforming data into recommended actions, laboratories can accelerate decision-making, optimize resource utilization, and proactively improve overall productivity.
